DK1054860T3 - Proces for syntesen af 1,3-dioler - Google Patents
Proces for syntesen af 1,3-diolerInfo
- Publication number
- DK1054860T3 DK1054860T3 DK98961855T DK98961855T DK1054860T3 DK 1054860 T3 DK1054860 T3 DK 1054860T3 DK 98961855 T DK98961855 T DK 98961855T DK 98961855 T DK98961855 T DK 98961855T DK 1054860 T3 DK1054860 T3 DK 1054860T3
- Authority
- DK
- Denmark
- Prior art keywords
- diols
- synthesis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B41/00—Formation or introduction of functional groups containing oxygen
- C07B41/02—Formation or introduction of functional groups containing oxygen of hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/19—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
- C07C255/20—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/19—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
- C07C255/21—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton the carbon skeleton being further substituted by doubly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6819397P | 1997-12-19 | 1997-12-19 | |
PCT/US1998/025493 WO1999032434A1 (en) | 1997-12-19 | 1998-12-02 | Process for the synthesis of 1,3-diols |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1054860T3 true DK1054860T3 (da) | 2007-07-02 |
Family
ID=22081016
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98961855T DK1054860T3 (da) | 1997-12-19 | 1998-12-02 | Proces for syntesen af 1,3-dioler |
Country Status (31)
Country | Link |
---|---|
US (4) | US6433213B1 (es) |
EP (1) | EP1054860B1 (es) |
JP (1) | JP2001526256A (es) |
KR (2) | KR100681366B1 (es) |
AR (1) | AR014943A1 (es) |
AT (1) | ATE360608T1 (es) |
AU (1) | AU755543B2 (es) |
BR (1) | BR9813760A (es) |
CA (1) | CA2305618C (es) |
CO (1) | CO4990941A1 (es) |
CU (1) | CU22939A3 (es) |
CY (1) | CY1106612T1 (es) |
DE (1) | DE69837681T2 (es) |
DK (1) | DK1054860T3 (es) |
ES (1) | ES2284219T3 (es) |
GT (2) | GT199800197AA (es) |
HN (1) | HN1998000187A (es) |
HU (1) | HUP0100252A3 (es) |
IL (1) | IL135562A (es) |
IS (1) | IS5447A (es) |
MY (1) | MY118726A (es) |
NO (1) | NO20003139D0 (es) |
NZ (1) | NZ504346A (es) |
PA (1) | PA8464901A1 (es) |
PE (1) | PE20000136A1 (es) |
PL (1) | PL193678B1 (es) |
PT (1) | PT1054860E (es) |
SV (1) | SV1998000153A (es) |
TW (1) | TW444000B (es) |
WO (1) | WO1999032434A1 (es) |
ZA (1) | ZA9811586B (es) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA02004078A (es) | 1999-12-17 | 2002-10-11 | Warner Lambert Res & Dev | Un proceso a escala industrial para producir sal de hemi calcio de trihidrato de atorvastatin cristalino. |
WO2001044181A1 (en) | 1999-12-17 | 2001-06-21 | Warner Lambert Research And Development Ireland Limited | A process for producing crystalline atorvastatin calcium |
US7521216B2 (en) * | 1999-12-29 | 2009-04-21 | Verenium Corporation | Nitrilases and methods for making and using them |
US7608445B1 (en) | 1999-12-29 | 2009-10-27 | Verenium Corporation | Nitrilases, nucleic acids encoding them and methods for making and using them |
US7300775B2 (en) | 1999-12-29 | 2007-11-27 | Verenium Corporation | Methods for producing α-substituted carboxylic acids using nitrilases and strecker reagents |
US20040014195A1 (en) * | 1999-12-29 | 2004-01-22 | Diversa Corporation | Nitrilases, nucleic acids encoding them and methods for making and using them |
RU2260001C2 (ru) * | 2001-04-05 | 2005-09-10 | Ниссан Кемикал Индастриз, ЛТД | Способ получения 7-хинолинил-3,5-дигидроксигепт-6-еноата |
IL159719A0 (en) * | 2001-07-06 | 2004-06-20 | Teva Pharma | Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives via 6-cyano syn 3,5-dihydroxy hexanoic acid derivatives |
SK792004A3 (sk) * | 2001-07-06 | 2005-03-04 | Teva Pharmaceutical Industries Ltd. | Syntéza a medziprodukty derivátov 3,5-dihydroxyheptánovej kyseliny |
GB0211715D0 (en) * | 2002-05-22 | 2002-07-03 | Phoenix Chemicals Ltd | Process |
US7932064B2 (en) | 2002-06-13 | 2011-04-26 | Verenium Corporation | Processes for making (R)-ethyl 4-cyano-3-hydroxybutyric acid |
DE60336324D1 (de) * | 2002-08-09 | 2011-04-21 | Codexis Inc | Enzymatische verfahren zur herstellung 4-substituierter 3-hydroxybuttersäure-derivate |
EP1631533B1 (en) * | 2003-04-22 | 2009-03-11 | Biocon Limited | Novel process for stereoselective reduction of beta-ketoesters |
US7790197B2 (en) * | 2003-06-09 | 2010-09-07 | Warner-Lambert Company Llc | Pharmaceutical compositions of atorvastatin |
US20050271717A1 (en) * | 2003-06-12 | 2005-12-08 | Alfred Berchielli | Pharmaceutical compositions of atorvastatin |
US7655692B2 (en) * | 2003-06-12 | 2010-02-02 | Pfizer Inc. | Process for forming amorphous atorvastatin |
US20040253305A1 (en) * | 2003-06-12 | 2004-12-16 | Luner Paul E. | Pharmaceutical compositions of atorvastatin |
CA2533838A1 (en) * | 2003-08-11 | 2005-02-24 | Codexis, Inc. | Improved ketoreductase polypeptides and related polynucleotides |
KR20060064620A (ko) * | 2003-08-11 | 2006-06-13 | 코덱시스, 인코포레이티드 | 개선된 글루코스 데히드로게나제 폴리펩티드 및 관련폴리뉴클레오티드 |
KR20060071397A (ko) * | 2003-08-11 | 2006-06-26 | 코덱시스, 인코포레이티드 | 4-치환된 3-히드록시부티르산 유도체 및 이웃자리 시아노,히드록시 치환된 카르복실산 에스테르의 효소적 제조 방법 |
US7541171B2 (en) * | 2003-08-11 | 2009-06-02 | Codexis, Inc. | Halohydrin dehalogenases and related polynucleotides |
US7588928B2 (en) * | 2003-08-11 | 2009-09-15 | Codexis, Inc. | Halohydrin dehalogenases and related polynucleotides |
US7824898B2 (en) | 2003-08-11 | 2010-11-02 | Codexis, Inc. | Halohydrin dehalogenases and related polynucleotides |
CN1852894A (zh) * | 2003-09-17 | 2006-10-25 | 沃尼尔·朗伯有限责任公司 | [R-(R*, R*)]-2-(4-氟苯基) -β,δ-二羟基-5-(1-甲基乙基) -3-苯基-4-[(苯基氨基)羰基] -1 H-吡咯-1-庚酸的结晶形式 |
AU2003272080A1 (en) * | 2003-09-18 | 2005-04-06 | Biocon Limited | Novel process for the preparation of tert-butyl 6-cyano-5-hydroxy-3-oxohexanoate |
US7851624B2 (en) * | 2003-12-24 | 2010-12-14 | Teva Pharamaceutical Industries Ltd. | Triol form of rosuvastatin and synthesis of rosuvastatin |
WO2005063728A2 (en) * | 2003-12-24 | 2005-07-14 | Teva Pharmaceutical Industries Ltd. | Process for preparation of statins with high syn to anti ratio |
CA2562844A1 (en) * | 2004-04-16 | 2005-10-27 | Pfizer Products Inc. | Process for forming amorphous atorvastatin calcium |
CA2649054A1 (en) | 2004-05-05 | 2005-11-10 | Pfizer Products Inc. | Salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-.beta., .delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid |
ES2586561T3 (es) * | 2004-07-16 | 2016-10-17 | Lek Pharmaceuticals D.D. | Productos de degradación oxidativa de atorvastatina calcio |
MX2007000765A (es) | 2004-07-20 | 2007-03-28 | Warner Lambert Co | Formas cristalinas de sal de calcio del acido (r-(r*, r*))-2- (4-fluorofenil)- beta,gama- dihidroxi-5- (1-metiletil)-3 -fenil-4-((fenilamino) (carbonil)-1ih -pirrol-1- heptanoico (2:1). |
MX2007004722A (es) * | 2004-10-28 | 2007-06-15 | Warner Lambert Co | Procedimiento para formar atorvastatina amorfa. |
EP1819319A1 (en) * | 2004-12-02 | 2007-08-22 | Warner-Lambert Company LLC | Pharmaceutical compositions of amorphous atorvastatin and process for preparing same |
JP2009507822A (ja) * | 2005-09-09 | 2009-02-26 | ファイザー・サイエンス・アンド・テクノロジー・アイルランド・リミテッド | アトルバスタチン中間体の調製 |
JP2009507821A (ja) * | 2005-09-09 | 2009-02-26 | ファイザー・サイエンス・アンド・テクノロジー・アイルランド・リミテッド | アトルバスタチン中間体の調製 |
CA2547216A1 (en) | 2005-09-21 | 2007-03-21 | Renuka D. Reddy | Process for annealing amorphous atorvastatin |
PT1957452E (pt) | 2005-11-21 | 2010-05-25 | Warner Lambert Co | Novas formas de ácido [r-(r*,r*)]-2-(4-fluorofenil)-b,b--di-hidroxi-5-(1-metiletil)-3-fenil-4-[(fenilamino)-carbonil]-1h-pirrole-1-heptanóico magnésico |
WO2008042876A2 (en) | 2006-10-02 | 2008-04-10 | Codexis, Inc. | Compositions and methods for producing stereoisomerically pure statins and synthetic intermediates therefor |
DK2115153T3 (da) | 2007-03-01 | 2013-09-08 | Bp Corp North America Inc | Nitrilaser, nucleinsyrer som koder for dem og fremgangsmåder til at fremstille og anvende disse |
WO2009137691A2 (en) * | 2008-05-09 | 2009-11-12 | The Scripps Research Institute | 1,3-diol synthesis via controlled, radical-mediated c-h functionalization |
SG172231A1 (en) | 2008-12-18 | 2011-07-28 | Codexis Inc | Recombinant halohydrin dehalogenase polypeptides |
EP2327682A1 (en) | 2009-10-29 | 2011-06-01 | KRKA, D.D., Novo Mesto | Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates |
EP2373609B1 (en) | 2008-12-19 | 2013-10-16 | KRKA, D.D., Novo Mesto | Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates |
WO2012158833A2 (en) * | 2011-05-16 | 2012-11-22 | The Regents Of The University Of California | Methods for production of hydrocarbons and oxygen-containing hydrocarbons |
CN103702982A (zh) | 2011-07-01 | 2014-04-02 | 中化帝斯曼制药有限公司荷兰公司 | 阿托伐他汀半钙的超细晶体 |
CN108033899B (zh) * | 2017-12-06 | 2020-04-10 | 浙江科技学院 | 一种(r)-6-氰基-5-羟基-3-羰基己酸叔丁酯的制备方法 |
CN111978286A (zh) * | 2020-08-21 | 2020-11-24 | 江苏万年长药业有限公司 | 一种制备ats-8的方法 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR64043B (en) | 1977-10-01 | 1980-01-19 | Expansia Sa | Borane complexes |
DE2912708A1 (de) | 1979-03-30 | 1980-10-09 | Basf Ag | Datenspeichersystem und magnetscheiben dafuer |
US5169857A (en) * | 1988-01-20 | 1992-12-08 | Bayer Aktiengesellschaft | 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis |
US5354772A (en) | 1982-11-22 | 1994-10-11 | Sandoz Pharm. Corp. | Indole analogs of mevalonolactone and derivatives thereof |
US4645854A (en) | 1985-04-25 | 1987-02-24 | Merck & Co., Inc. | Process for preparing HMG-CoA reductase inhibitors with a 3,5-dihydroxypentanoate subunit |
US4898949A (en) * | 1987-02-25 | 1990-02-06 | Bristol-Myers Company | Intermediates for the preparation of antihypercholesterolemic tetrazole compounds |
US4897490A (en) * | 1987-02-25 | 1990-01-30 | Bristol-Meyers Company | Antihypercholesterolemic tetrazole compounds |
DE3741509A1 (de) | 1987-12-08 | 1989-06-22 | Hoechst Ag | Verfahren zur herstellung optisch aktiver 3-desmethylmevalonsaeurederivate sowie zwischenprodukte |
US5001144A (en) * | 1987-12-21 | 1991-03-19 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted cyclohexene derivatives as HMG-CoA reductase inhibitors |
US5003080A (en) * | 1988-02-22 | 1991-03-26 | Warner-Lambert Company | Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis |
FR2642065B1 (fr) * | 1989-01-24 | 1991-05-24 | Lipha | Derives d'acides benzocycloalcenyl dihydroxy alcanoiques, procede de preparation et medicaments les contenant |
FI94339C (fi) * | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
DE3929507A1 (de) * | 1989-09-06 | 1991-03-07 | Bayer Ag | Substituierte amino-pyridine |
US5039802A (en) | 1990-04-18 | 1991-08-13 | Merck & Co., Inc. | Arylation process for preparation of chiral catalysts for ketone reduction |
JP3528186B2 (ja) | 1991-06-24 | 2004-05-17 | 日産化学工業株式会社 | 光学活性キノリンメバロン酸のジアステレオマー塩 |
US5155251A (en) | 1991-10-11 | 1992-10-13 | Warner-Lambert Company | Process for the synthesis of (5R)-1,1-dimethylethyl-6-cyano-5-hydroxy-3-oxo-hexanoate |
US5218138A (en) * | 1992-09-02 | 1993-06-08 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Stereoselective reduction of 3-hydroxyket-1-ones to 1,3-syn-dihydroxylated compounds |
US5298627A (en) * | 1993-03-03 | 1994-03-29 | Warner-Lambert Company | Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
-
1998
- 1998-12-02 KR KR1020067012766A patent/KR100681366B1/ko not_active IP Right Cessation
- 1998-12-02 AT AT98961855T patent/ATE360608T1/de not_active IP Right Cessation
- 1998-12-02 HU HU0100252A patent/HUP0100252A3/hu unknown
- 1998-12-02 PL PL98341294A patent/PL193678B1/pl not_active IP Right Cessation
- 1998-12-02 DE DE69837681T patent/DE69837681T2/de not_active Expired - Fee Related
- 1998-12-02 DK DK98961855T patent/DK1054860T3/da active
- 1998-12-02 BR BR9813760-3A patent/BR9813760A/pt not_active Application Discontinuation
- 1998-12-02 JP JP2000525371A patent/JP2001526256A/ja not_active Abandoned
- 1998-12-02 US US09/581,798 patent/US6433213B1/en not_active Expired - Fee Related
- 1998-12-02 PT PT98961855T patent/PT1054860E/pt unknown
- 1998-12-02 NZ NZ504346A patent/NZ504346A/en unknown
- 1998-12-02 CA CA002305618A patent/CA2305618C/en not_active Expired - Fee Related
- 1998-12-02 WO PCT/US1998/025493 patent/WO1999032434A1/en active IP Right Grant
- 1998-12-02 IL IL13556298A patent/IL135562A/xx not_active IP Right Cessation
- 1998-12-02 ES ES98961855T patent/ES2284219T3/es not_active Expired - Lifetime
- 1998-12-02 AU AU17074/99A patent/AU755543B2/en not_active Ceased
- 1998-12-02 KR KR1020007006762A patent/KR100668575B1/ko not_active IP Right Cessation
- 1998-12-02 EP EP98961855A patent/EP1054860B1/en not_active Expired - Lifetime
- 1998-12-09 HN HN1998000187A patent/HN1998000187A/es unknown
- 1998-12-14 GT GT199800197AK patent/GT199800197AA/es unknown
- 1998-12-14 GT GT199800197A patent/GT199800197A/es unknown
- 1998-12-17 MY MYPI98005721A patent/MY118726A/en unknown
- 1998-12-17 ZA ZA9811586A patent/ZA9811586B/xx unknown
- 1998-12-18 TW TW087121215A patent/TW444000B/zh not_active IP Right Cessation
- 1998-12-18 SV SV1998000153A patent/SV1998000153A/es not_active Application Discontinuation
- 1998-12-18 PA PA19988464901A patent/PA8464901A1/es unknown
- 1998-12-18 CO CO98075429A patent/CO4990941A1/es unknown
- 1998-12-18 AR ARP980106461A patent/AR014943A1/es active IP Right Grant
- 1998-12-18 PE PE1998001245A patent/PE20000136A1/es not_active Application Discontinuation
-
2000
- 2000-04-14 IS IS5447A patent/IS5447A/is unknown
- 2000-06-09 CU CU20000144A patent/CU22939A3/es not_active IP Right Cessation
- 2000-06-16 NO NO20003139A patent/NO20003139D0/no not_active Application Discontinuation
-
2002
- 2002-06-11 US US10/166,990 patent/US6596879B2/en not_active Expired - Fee Related
-
2003
- 2003-04-11 US US10/411,886 patent/US6962994B2/en not_active Expired - Fee Related
-
2005
- 2005-04-29 US US11/119,151 patent/US7232915B2/en not_active Expired - Fee Related
-
2007
- 2007-05-21 CY CY20071100687T patent/CY1106612T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1054860T3 (da) | Proces for syntesen af 1,3-dioler | |
DK0773940T4 (da) | Fremgangsmåde til syntese af substituerede sulfoxider | |
FI19992060A (fi) | Prosessikojeen alusta | |
DK0770615T3 (da) | Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner | |
DK0858440T3 (da) | Fremgangsmåde til fremstilling af 1,1,1,3,3-pentafluorpropan | |
DK0911416T3 (da) | Fremgangsmåde til fremstilling af protein | |
DK0937055T3 (da) | Fremgangsmåde til fremstilling af d,I-alfa-tocopherol | |
DK1027315T3 (da) | Fremgangsmåde til fremstilling af n-butanol | |
DK1028960T3 (da) | Fremgangsmåde til fremstilling af thiazolidinedion | |
DK0970939T3 (da) | Fremgangsmåde til fremstilling af methanol | |
DK0973769T3 (da) | Fremgangsmåde til fremstilling af eprosartan | |
DK0927766T3 (da) | Enzymatisk fremgangsmåde til fremstilling af (S)-cyanhydriner | |
FI971035A (fi) | Biokonversioprosessi trans-hydroksisulfonin syntetisoimiseksi | |
DK0815092T3 (da) | Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner | |
DK0842930T3 (da) | Fremgangsmåde til syntese af benzothiophener | |
NO963187D0 (no) | Fremgangsmåte for syntese av gamma-pyroner | |
DK0970073T3 (da) | Fremgangsmåde til fremstilling af eprosartan | |
DK1075473T3 (da) | Fremgangsmåde til fremstilling af 1,3-disubstituerede-4-oxocykliske urinstoffer | |
DK0735043T3 (da) | Fremgangsmåde til fremstilling af 2-substitueret 3,3-difluorfuran | |
DK1023292T3 (da) | Fremgangsmåde til syntese af chlorpurinintermediater | |
IS5162A (is) | Aðferð við að framleiða efnasambönd úr bensóþíasólóni | |
FI961827A0 (fi) | Menetelmä 1,3-diolien monoesterien valmistamiseksi | |
DK1012152T3 (da) | Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer | |
DK0721929T3 (da) | Fremgangsmåde til fremstilling af hydroxyalkoxybenzophenoner | |
DK0863874T3 (da) | Fremgangsmåde til fremstilling af dioxoazabicyclohexaner |